Skip to main content
Top
Published in: Annals of Hematology 5/2017

Open Access 01-05-2017 | Original Article

Gene expression signature for early prediction of late occurring pancytopenia in irradiated baboons

Authors: Matthias Port, Francis Hérodin, Marco Valente, Michel Drouet, Andreas Lamkowski, Matthäus Majewski, Michael Abend

Published in: Annals of Hematology | Issue 5/2017

Login to get access

Abstract

Based on gene expression changes measured in the peripheral blood within the first 2 days after irradiation, we predicted a pancytopenia in a baboon model. Eighteen baboons were irradiated with 2.5 or 5 Gy. According to changes in blood cell counts, the surviving baboons (n = 17) exhibited a hematological acute radiation syndrome (HARS) either with or without a pancytopenia. We used a two stage study design where stage I was a whole genome screen (microarrays) for mRNA combined with a qRT-PCR platform for simultaneous detection of 667 miRNAs using a part of the samples. Candidate mRNAs and miRNAs differentially upregulated or downregulated (>2-fold, p < 0.05) during the first 2 days after irradiation were chosen for validation in stage II using the remaining samples and using throughout more sensitive qRT-PCR. We detected about twice as many upregulated (mean 2128) than downregulated genes (mean 789) in baboons developing an HARS either with or without a pancytopenia. From 51 candidate mRNAs altogether, 11 mRNAs were validated using qRT-PCR. These mRNAs showed only significant differences between HARS groups and H0, but not between HARS groups with and without pancytopenia. Six miRNA species (e.g., miR-574-3p, p = 0.009, ROC = 0.94) revealed significant gene expression differences between HARS groups with and without pancytopenia and are known to sensitize irradiated cells. Hence, in particular, the newly identified miRNA species for prediction of pancytopenia will support the medical management decision making.
Appendix
Available only for authorised users
Literature
5.
go back to reference Port M, Herodin F, Valente M, et al. (2016) First generation gene expression signature for early prediction of late occurring hematological acute radiation syndrome in baboons. 000:39–54. doi:10.1667/RR14318.1 Port M, Herodin F, Valente M, et al. (2016) First generation gene expression signature for early prediction of late occurring hematological acute radiation syndrome in baboons. 000:39–54. doi:10.​1667/​RR14318.​1
6.
8.
go back to reference Flowers CR, Seidenfeld J, Bow EJ et al (2013) Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31:794–810. doi:10.1200/JCO.2012.45.8661 CrossRefPubMed Flowers CR, Seidenfeld J, Bow EJ et al (2013) Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31:794–810. doi:10.​1200/​JCO.​2012.​45.​8661 CrossRefPubMed
13.
go back to reference Aavik E, Mahapatra A, Boldrick J et al (2005) Correlation between gene expression and morphological alterations in baboon carotid after balloon dilatation injury. FASEB J 19:130–132. doi:10.1096/fj.04-2225fje PubMed Aavik E, Mahapatra A, Boldrick J et al (2005) Correlation between gene expression and morphological alterations in baboon carotid after balloon dilatation injury. FASEB J 19:130–132. doi:10.​1096/​fj.​04-2225fje PubMed
Metadata
Title
Gene expression signature for early prediction of late occurring pancytopenia in irradiated baboons
Authors
Matthias Port
Francis Hérodin
Marco Valente
Michel Drouet
Andreas Lamkowski
Matthäus Majewski
Michael Abend
Publication date
01-05-2017
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 5/2017
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-017-2952-7

Other articles of this Issue 5/2017

Annals of Hematology 5/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.